Neonatal Respiratory Distress Syndrome, Lung Ultrasound, Diagnosis, Application Progress Share and Cite: Zhang, C. and Wang, B. (2025) Advances in the Application of Lung Ultrasound in the Diagnosis ...

A gene change may explain why some newborn babies struggle for breath, and could lead to genetic biomarker-based tests to warn of the risk. Neonatal respiratory distress syndrome (RDS) is a breathing ...

Please provide your email address to receive an email when new articles are posted on . Minimally invasive surfactant therapy did not lower mortality among preterm infants with respiratory distress ...

Objective: The aim of the study was to measure pulmonary mechanics in infants with respiratory distress syndrome before extubation and to correlate pulmonary function values with successful extubation ...

The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant ...

The intubation-surfactant-extubation (INSURE) procedure is used worldwide to treat preterm newborn infants suffering from respiratory distress syndrome, which is caused by an insufficient amount of ...

THE respiratory-distress syndrome, or hyalinemembrane disease, is the commonest cause of death among newborn, especially premature, infants, and yet its pathogenesis remains a mystery and its ...

HealthDay News — The FDA has approved Surfaxin (lucinactant) to prevent respiratory distress syndrome (RDS) in premature infants. Premature infants born before 37 weeks’ gestation often cannot produce ...

This is a preview. Log in through your library . Abstract Although substantial declines in infant mortality rates have occurred across racial/ethnic groups, there has been a marked increase in ...

Neonatal Respiratory Distress Syndrome (NRDS) remains a pressing concern in neonatal care, being a leading cause of morbidity among newborn infants. Its aetiology is frequently linked to surfactant ...